aWe were developing a language among ourselves. If Admiral Byrd and an exploratory party are going deeper and deeper into the polar region, the things they think about and are concerned about and are interested in become less and less relevant to somebody living in New York City. This was ou...
What if it’s true that a Nazi assistance program has been going on in underground facilities in the US, Antarctica, and Argentina since the first half of the 20th Century, prior to Admiral Byrd’s military expedition to Antarctica (in which he apparently suffered defeat and was forced to r...
It's the Willcutts Review Board, named for Rear Admiral Morton D. Willcutts, the head of the National Naval Medical Center. The Review Board took the testimony of all witnesses and finished its work on May 30. It was not until October 11, however, that its conclusions were released to ...
(; February 24, 1885 – February 20, 1966) was a fleet admiral of the United States Navy. He played a major role in the naval history of World War II as Commander in Chief, U.S. Pacific Fleet and Commander in Chief, Pacific Ocean Areas, commanding Allied air, land, and sea forces...
The climate is not likely to offer an insuperable problem, for the explorer Admiral Byrd has shown that the climate is possible even for men completely untrained for expeditions into those frozen wastes. Some of his parties were men who had never seen snow before, and yet he records that the...
Dickey Chapelle jumped out of planes, marched through the jungle and survived enemy prison—redefining what it meant to be a woman on the front lines.
as well as by Admiral Richard Byrd and Hubert Wilkins on their polar flights. Gatty and Weems had much in common and enjoyed working together. The system they developed led to Weems’ generously declaring that Gatty ‘has done more practical work on celestial navigation than any other person in...
CML is the main TK-dependent cancer because it was the first to be targeted by an FDA-approved therapy, the anti-ABL TKI imatinib. In AML, the FLT3 receptor, which is usually present on HSPC, is frequently overexpressed and mutated at diagnosis through an internal tandem duplication (25%,...
Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the phase III ADMIRAL trial. In Proceedings of the AACR Annual Meeting, Atlanta, GA, USA, 29 March–3 April 2019. Int. J. Mol...